The Role of Oral SERDs in ER+/HER2- Metastatic Breast Cancer
Opinion
Video
Focusing on elacestrant, Dr Graff discusses the role of oral SERDs (selective estrogen receptor degraders) in the treatment of patients with ER+/HER2- metastatic breast cancer.